Kilitch Drugs (India) Ltd
Kilitch Drugs | 524500
KILITCH - Share Price Chart
Stock Performance
Ratios
About Company
- Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe
- Its services range from manufacturing to marketing a host of formulations in all dosage forms i
- solid, liquid and parenteral forms of creating safe pharmaceutical solutions
- The Company went public in Feb
- '94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules, liquid orals, ointments, creams and injectables
- Even before the plant was commissioned, the company came out with a rights issue in Oct
- '95 to expand the capacity
- Commercial production at the plant at Thane commenced in 1996
- The company has two divisions - O T C and ethical
- A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Kilitch Drugs (India) Ltd?
The current share price of Kilitch Drugs (India) Ltd (Kilitch Drugs) is ₹162.33. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Kilitch Drugs (India) Ltd?
The Price-to-Earnings (P/E) ratio of Kilitch Drugs (India) Ltd is 162.33. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd has a 52-week high of ₹219.50 and a 52-week low of ₹117.25. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Kilitch Drugs (India) Ltd?
The Earnings Per Share (EPS) of Kilitch Drugs (India) Ltd is ₹8.60. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd has a Return on Equity (ROE) of 11.06%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
